Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 168

1.

Trimethoprim-sulfamethoxazole induced hyperkalaemia in elderly patients receiving spironolactone: nested case-control study.

Antoniou T, Gomes T, Mamdani MM, Yao Z, Hellings C, Garg AX, Weir MA, Juurlink DN.

BMJ. 2011 Sep 12;343:d5228. doi: 10.1136/bmj.d5228.

2.

Trimethoprim-sulfamethoxazole and risk of sudden death among patients taking spironolactone.

Antoniou T, Hollands S, Macdonald EM, Gomes T, Mamdani MM, Juurlink DN; Canadian Drug Safety and Effectiveness Research Network.

CMAJ. 2015 Mar 3;187(4):E138-43. doi: 10.1503/cmaj.140816. Epub 2015 Feb 2.

3.

Trimethoprim-sulfamethoxazole-induced hyperkalemia in patients receiving inhibitors of the renin-angiotensin system: a population-based study.

Antoniou T, Gomes T, Juurlink DN, Loutfy MR, Glazier RH, Mamdani MM.

Arch Intern Med. 2010 Jun 28;170(12):1045-9. doi: 10.1001/archinternmed.2010.142.

PMID:
20585070
4.

Co-trimoxazole and sudden death in patients receiving inhibitors of renin-angiotensin system: population based study.

Fralick M, Macdonald EM, Gomes T, Antoniou T, Hollands S, Mamdani MM, Juurlink DN; Canadian Drug Safety and Effectiveness Research Network.

BMJ. 2014 Oct 30;349:g6196. doi: 10.1136/bmj.g6196.

5.

Hemorrhage during warfarin therapy associated with cotrimoxazole and other urinary tract anti-infective agents: a population-based study.

Fischer HD, Juurlink DN, Mamdani MM, Kopp A, Laupacis A.

Arch Intern Med. 2010 Apr 12;170(7):617-21. doi: 10.1001/archinternmed.2010.37.

PMID:
20386005
6.

Beta-blockers, trimethoprim-sulfamethoxazole, and the risk of hyperkalemia requiring hospitalization in the elderly: a nested case-control study.

Weir MA, Juurlink DN, Gomes T, Mamdani M, Hackam DG, Jain AK, Garg AX.

Clin J Am Soc Nephrol. 2010 Sep;5(9):1544-51. doi: 10.2215/CJN.01970310. Epub 2010 Jul 1.

7.

Drug-drug interactions among elderly patients hospitalized for drug toxicity.

Juurlink DN, Mamdani M, Kopp A, Laupacis A, Redelmeier DA.

JAMA. 2003 Apr 2;289(13):1652-8.

PMID:
12672733
8.

Co-prescription of co-trimoxazole and spironolactone in elderly patients.

Wei L, MacDonald TM, Mackenzie IS.

BMJ. 2011 Sep 12;343:d5656. doi: 10.1136/bmj.d5656. No abstract available.

PMID:
21911447
9.

Trimethoprim/sulfamethoxazole-induced phenytoin toxicity in the elderly: a population-based study.

Antoniou T, Gomes T, Mamdani MM, Juurlink DN.

Br J Clin Pharmacol. 2011 Apr;71(4):544-9. doi: 10.1111/j.1365-2125.2010.03866.x.

10.

ACP Journal Club. Trimethoprim-sulfamethoxazole was linked to sudden death in older patients using spironolactone.

Ananthakrishnan S.

Ann Intern Med. 2015 Jun 16;162(12):JC13. doi: 10.7326/ACPJC-2015-162-12-013. No abstract available.

PMID:
26075778
11.

Hospital admissions for hyperkalemia with trimethoprim-sulfamethoxazole: a cohort study using health care database codes for 393,039 older women with urinary tract infections.

Lam N, Weir MA, Juurlink DN, Gunraj N, Gomes T, Mamdani M, Hackam DG, Jain AK, Garg AX.

Am J Kidney Dis. 2011 Mar;57(3):521-3. doi: 10.1053/j.ajkd.2010.11.006. Epub 2011 Jan 8. No abstract available.

PMID:
21216514
12.

Influence of concomitant prednisolone on trimethoprim-associated hyperkalaemia.

Mohan S, Jaitly M, Pogue VA, Cheng JT.

J Antimicrob Chemother. 2009 Oct;64(4):850-2. doi: 10.1093/jac/dkp280. Epub 2009 Aug 4.

13.

Hyperkalemia in hospitalized patients treated with trimethoprim-sulfamethoxazole.

Alappan R, Perazella MA, Buller GK.

Ann Intern Med. 1996 Feb 1;124(3):316-20.

PMID:
8554227
14.

Refractory hyperkalaemia due to trimethoprim, successfully treated with fludrocortisone.

Sanjay S, Annigeri RA, Gopalakrishnan R.

J Assoc Physicians India. 2007 Jan;55:74-5.

PMID:
17444347
15.

Detection of spironolactone-associated hyperkalaemia following the Randomized Aldactone Evaluation Study (RALES).

Hauben M, Reich L, Gerrits CM, Madigan D.

Drug Saf. 2007;30(12):1143-9.

PMID:
18035866
16.

Hyperkalaemia in congestive heart failure patients using ACE inhibitors and spironolactone.

Cruz CS, Cruz AA, MarcĂ­lio de Souza CA.

Nephrol Dial Transplant. 2003 Sep;18(9):1814-9.

17.

Spironolactone use and renal toxicity: population based longitudinal analysis.

Wei L, Struthers AD, Fahey T, Watson AD, Macdonald TM.

BMJ. 2010 May 18;340:c1768. doi: 10.1136/bmj.c1768.

18.

Kidney function and the use of nitrofurantoin to treat urinary tract infections in older women.

Singh N, Gandhi S, McArthur E, Moist L, Jain AK, Liu AR, Sood MM, Garg AX.

CMAJ. 2015 Jun 16;187(9):648-56. doi: 10.1503/cmaj.150067. Epub 2015 Apr 27.

19.

Adverse reactions of nitrofurantoin, trimethoprim and sulfamethoxazole in children.

Karpman E, Kurzrock EA.

J Urol. 2004 Aug;172(2):448-53. Review.

PMID:
15247700
20.

Trimethoprim-sulfamethoxazole therapy in outpatients: is hyperkalemia a significant problem?

Alappan R, Buller GK, Perazella MA.

Am J Nephrol. 1999;19(3):389-94.

PMID:
10393376
Items per page

Supplemental Content

Write to the Help Desk